Concentrix Files 8-K on Financial Condition & Results
Ticker: CNXC · Form: 8-K · Filed: Jan 24, 2024 · CIK: 1803599
Complexity: simple
Sentiment: neutral
Topics: financial-condition, results-of-operations, 8-K, corporate-filing
TL;DR
**Concentrix just filed an 8-K about its financial results, so expect more details soon.**
AI Summary
Concentrix Corporation filed an 8-K on January 24, 2024, to report on its 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits.' This filing indicates that the company is providing an update on its financial performance, which is crucial for investors to understand the company's current health and future prospects. While specific numbers aren't detailed in this particular filing, the fact that they are reporting these items means investors should anticipate or look for the actual financial results to assess the company's profitability and stability.
Why It Matters
This filing signals that Concentrix is updating the market on its financial performance, which is essential for investors to gauge the company's health and make informed decisions about buying, holding, or selling its stock.
Risk Assessment
Risk Level: low — This 8-K is a routine disclosure of financial information, not indicating any immediate negative events or significant changes in company operations.
Analyst Insight
A smart investor would monitor Concentrix's upcoming financial disclosures for specific revenue, profit, and guidance figures to assess the company's performance and adjust their investment strategy accordingly.
Key Numbers
- $0.0001 — par value per share (par value of Concentrix Common Stock)
Key Players & Entities
- Concentrix Corporation (company) — the registrant filing the 8-K
- Delaware (company) — state of incorporation for Concentrix Corporation
- The Nasdaq Stock Market LLC (company) — exchange where Concentrix Common Stock is registered
- 001-39494 (dollar_amount) — Commission File Number
- 27-1605762 (dollar_amount) — I.R.S. Employer Identification Number
- January 24, 2024 (date) — Date of Report (Date of Earliest Event Reported)
Forward-Looking Statements
- Concentrix will release detailed financial results soon, likely within the next few days or weeks, following this 8-K filing. (Concentrix Corporation) — high confidence, target: 2024-02-15
- The market will react to the specific financial figures once they are disclosed, potentially impacting CNXC's stock price. (CNXC) — medium confidence, target: 2024-02-29
FAQ
What is the purpose of Concentrix Corporation's 8-K filing on January 24, 2024?
The 8-K filing by Concentrix Corporation on January 24, 2024, is to report on 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits' as per Item 2.02 and Item 9.01 of Form 8-K.
What is the trading symbol and exchange for Concentrix Corporation's Common Stock?
The trading symbol for Concentrix Corporation's Common Stock is CNXC, and it is registered on The Nasdaq Stock Market LLC.
What is the state of incorporation for Concentrix Corporation?
Concentrix Corporation is incorporated in Delaware.
What is the earliest event reported date in this 8-K filing?
The Date of Earliest Event Reported in this 8-K filing is January 24, 2024.
Is Concentrix Corporation considered an emerging growth company according to this filing?
No, Concentrix Corporation has indicated with a checkbox that it is not an emerging growth company.
Filing Stats: 517 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2024-01-24 16:08:51
Key Financial Figures
- $0.0001 — ich registered Common Stock, par value $0.0001 per share CNXC The Nasdaq Stock Market
Filing Documents
- cnxc-20240124.htm (8-K) — 28KB
- exhibit991q42023.htm (EX-99.1) — 378KB
- imagea.jpg (GRAPHIC) — 5KB
- 0001803599-24-000009.txt ( ) — 565KB
- cnxc-20240124.xsd (EX-101.SCH) — 2KB
- cnxc-20240124_lab.xml (EX-101.LAB) — 24KB
- cnxc-20240124_pre.xml (EX-101.PRE) — 13KB
- cnxc-20240124_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On January 24, 2024, Concentrix Corporation (the "Company" or "Concentrix") issued a press release reporting its financial results for the quarter and year ended November 30, 2023. A copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated in this Item 2.02 by reference. The information contained in this Current Report on Form 8-K is furnished pursuant to Item 2.02 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or incorporated by reference into any Concentrix filing or report with the Securities and Exchange Commission, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in any such filing or report.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press release issued by Concentrix Corporation on January 24, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 24, 2024 CONCENTRIX CORPORATION By: /s/ Andre Valentine Andre Valentine Chief Financial Officer